Skip to main content
Log in

Metoclopramide in a patient with renal failure may be an increased risk of neuroleptic malignant syndrome

  • Correspondence
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Guzé BH, Baxter LR (1985) Neuroleptic malignant syndrome. N Engl J Med 313:163–166

    Google Scholar 

  2. Samie MR (1987) Neuroleptic malignant-like syndrome induced by metoclopramide. Mov Disord 2:57–60

    Google Scholar 

  3. Friedman LS, Weinrauch LA, D'Elia JA (1987) Metoclopramide-induced neuroleptic malignant syndrome. Arch Intern Med 147:1495–1497

    Google Scholar 

  4. Krähenbühl S, Raisin J, Herren T (1993) Malignes neuroleptisches Syndrom unter Metoclopramide und Neuroleptika bei Anurie. Schweiz Med Wochenschr 123:1359–1362

    Google Scholar 

  5. Lehman CR, Heironimus JD, Collins CB, O'Neil J, Pierson WP, Crowe JR, Melikian AP, Wright GJ (1985) Metoclopramide kinetics in patients with impaired renal function and clearance by hemodialysis. Clin Pharmacol Ther 37:284–289

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fujita, Y., Yasukawa, T., Mihira, M. et al. Metoclopramide in a patient with renal failure may be an increased risk of neuroleptic malignant syndrome. Intensive Care Med 22, 717 (1996). https://doi.org/10.1007/BF01709759

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01709759

Keywords

Navigation